Who Gets to Be Perfect?
By Corin Faife,
How We Get To Next [cites CGS' Marcy Darnovsky]
| 09. 26. 2017
Editing the human genome has huge potential for improving health — for those who can afford it
Debojyoti Chakraborty smiles at me from his laboratory in New Delhi.Through the grainy resolution of our video call, I can just make out a button-up shirt and short black hair atop a boyish face; in the background, graduate students in lab coats drift in and out of shot. The CSIR-Institute of Genomics & Integrative Biology, where his lab is based, experiments with reprogramming adult tissue to take on the characteristics of embryonic stem cells, which can then grow into over 200 other cell types.
Chakraborty’s own research team is focused on two human diseases: a rare type of encephalitis and sickle-cell anemia. The latter is an inherited blood disorder, widespread across sub-Saharan Africa and among certain castes and tribal groups in India, in which the hemoglobin protein in red blood cells takes on an abnormal shape. This prevents the blood from carrying oxygen efficiently, leading to organ damage and severe pain. Because of the demographics of its genetic carriers, it disproportionately impacts poorer people...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
